XML 39 R32.htm IDEA: XBRL DOCUMENT v3.25.1
Stock-based Compensation (Tables)
3 Months Ended
Mar. 31, 2025
Stock-Based Compensation Expense by Award Type

The Company’s stock-based compensation expense by award type was as follows (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2025

 

 

2024

 

Stock options

 

$

4,707

 

 

$

5,978

 

Restricted stock units

 

 

3,668

 

 

 

3,447

 

Employee stock purchase plan

 

 

162

 

 

 

177

 

 

 

$

8,537

 

 

$

9,602

 

Stock-Based Compensation Expense

The Company recorded aggregate stock-based compensation expense in the consolidated statements of operations and comprehensive income (loss) as follows (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2025

 

 

2024

 

Research and development

 

$

3,947

 

 

$

4,893

 

General and administrative

 

 

4,590

 

 

 

4,709

 

 

 

$

8,537

 

 

$

9,602

 

Summary of Unvested RSUs Activity Under 2015 Plan

The following table summarizes restricted stock unit activity under the 2015 Plan (in thousands, except per share data):

 

 

 

 

 

 

Weighted-average

 

 

 

 

 

 

Grant Date

 

 

 

Shares

 

 

Fair Value

 

Unvested balance at December 31, 2024

 

 

2,042

 

 

$

19.95

 

Granted

 

 

894

 

 

$

7.84

 

Vested

 

 

(546

)

 

$

23.06

 

Forfeited

 

 

(55

)

 

$

19.01

 

Unvested balance at March 31, 2025

 

 

2,335

 

 

$

14.61

 

2014 and 2015 Equity Incentive Plan [Member]  
Summary of Stock Option Activity

The following table summarizes stock option activity under the 2014 Plan and 2015 Plan (in thousands, except per share data):

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

 

 

average

 

 

 

 

 

 

 

 

 

Weighted-

 

 

Remaining

 

 

 

 

 

 

 

 

 

average

 

 

Contractual

 

 

Aggregate

 

 

 

 

 

 

Exercise

 

 

Life

 

 

Intrinsic

 

 

 

Shares

 

 

Price

 

 

(Years)

 

 

Value (a)

 

Outstanding at December 31, 2024

 

 

9,994

 

 

$

29.48

 

 

 

5.9

 

 

$

240

 

Granted

 

 

2,032

 

 

$

7.85

 

 

 

 

 

 

 

Exercised

 

 

(40

)

 

$

3.76

 

 

 

 

 

 

 

Cancelled or forfeited

 

 

(156

)

 

$

22.09

 

 

 

 

 

 

 

Outstanding at March 31, 2025

 

 

11,830

 

 

$

25.95

 

 

 

6.4

 

 

$

84

 

Exercisable at March 31, 2025

 

 

7,388

 

 

$

33.26

 

 

 

4.8

 

 

$

70

 

Vested and expected to vest at March 31, 2025

 

 

11,830

 

 

$

25.95

 

 

 

6.4

 

 

$

84

 

 

(a)
The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the fair value of the common stock for the options that were in the money at the dates reported.